TriangleNCT00891618 · OUTCOME
Mean Neuropathy Severity Score (FACT-GOG-Ntx Total Score Assessment)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- units on a scale
- Interval / dispersion
- Standard Deviation
- Time frame
- Baseline to Week 13. Assessments at baseline, once per week during the two treatment phases of the study, and one month (week 13) after the last acupuncture treatment.
What was measured
Functional Assessment of Cancer Treatment - Gynecologic Oncology Group Neurotoxicity Scale (FACT/GOG-Ntx) Version 4 used to assess efficacy of acupuncture for treatment-induced peripheral neuropathy among multiple myeloma and/or lymphoma patients. Severity of neuropathy measured by FACT-GOG-Ntx total score assessment where 11-item questionnaire 5 point rating scale (0="not at all" and 4=equals "very much"). FACT/GOG-Ntx Total Score ranges from 0 (best possible outcome) to 44 (worst possible outcome).
Analysis population: Participants were excluded from primary outcome if did not complete follow up assessments.
Groups in this outcome
Acupuncture
Three (3) acupuncture sessions per week for 4 weeks (Weeks 1-4), 1 week off (Week 5), then 2 per week for 4 more weeks (Weeks 6-10), total of 20 sessions. Each session lasts 20-30 minutes.
| Group | Source count |
|---|---|
| Acupuncture | 19 |
Reported measurements
Baseline (n=19)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Acupuncture | 20.8 | 9.6 | Not reported | Not reported | Not reported |
Week 4 (n=18)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Acupuncture | 16.7 | 9.4 | Not reported | Not reported | Not reported |
Week 9 (n=15)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Acupuncture | 9.9 | 5.6 | Not reported | Not reported | Not reported |
Week 13 (n=15)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Acupuncture | 13.2 | 8.5 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 9.6
- value
- 20.8
- title
- Baseline (n=19)
- categories
- measurements
- group Id
- OG000
- spread
- 9.4
- value
- 16.7
- title
- Week 4 (n=18)
- categories
- measurements
- group Id
- OG000
- spread
- 5.6
- value
- 9.9
- title
- Week 9 (n=15)
- categories
- measurements
- group Id
- OG000
- spread
- 8.5
- value
- 13.2
- title
- Week 13 (n=15)
- denoms
- counts
- group Id
- OG000
- value
- 19
- units
- Participants
- description
- Functional Assessment of Cancer Treatment - Gynecologic Oncology Group Neurotoxicity Scale (FACT/GOG-Ntx) Version 4 used to assess efficacy of acupuncture for treatment-induced peripheral neuropathy among multiple myeloma and/or lymphoma patients. Severity of neuropathy measured by FACT-GOG-Ntx total score assessment where 11-item questionnaire 5 point rating scale (0="not at all" and 4=equals "very much"). FACT/GOG-Ntx Total Score ranges from 0 (best possible outcome) to 44 (worst possible outcome).
- dispersion Type
- Standard Deviation
- groups
- description
- Three (3) acupuncture sessions per week for 4 weeks (Weeks 1-4), 1 week off (Week 5), then 2 per week for 4 more weeks (Weeks 6-10), total of 20 sessions. Each session lasts 20-30 minutes.
- id
- OG000
- title
- Acupuncture
- param Type
- MEAN
- population Description
- Participants were excluded from primary outcome if did not complete follow up assessments.
- reporting Status
- POSTED
- time Frame
- Baseline to Week 13. Assessments at baseline, once per week during the two treatment phases of the study, and one month (week 13) after the last acupuncture treatment.
- title
- Mean Neuropathy Severity Score (FACT-GOG-Ntx Total Score Assessment)
- type
- PRIMARY
- unit Of Measure
- units on a scale
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice